Cargando…
Genomic profiling for copy number changes in plasma of ovarian cancer patients – a new era for cancer diagnostics?
A blood test that can detect human malignancy with high clinical sensitivity and specificity is highly desirable. To achieve this, a tumor marker is needed that correlates with tumor burden and that can be measured with high analytical sensitivity and specificity. Over the past decades, a number of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112646/ https://www.ncbi.nlm.nih.gov/pubmed/27852253 http://dx.doi.org/10.1186/s12916-016-0741-0 |